MH & Associates Securities Management Corp ADV acquired a new position in shares of Ambev S.A. (NYSE:ABEV - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 699,168 shares of the company's stock, valued at approximately $1,727,000.
A number of other large investors have also modified their holdings of the stock. Modern Wealth Management LLC purchased a new stake in shares of Ambev during the third quarter worth approximately $25,000. First Trust Advisors LP purchased a new stake in shares of Ambev during the third quarter worth approximately $25,000. Integrated Wealth Concepts LLC purchased a new stake in shares of Ambev during the first quarter worth approximately $26,000. Bensler LLC purchased a new stake in shares of Ambev during the third quarter worth approximately $27,000. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Ambev by 2,224.1% during the second quarter. EverSource Wealth Advisors LLC now owns 12,248 shares of the company's stock worth $30,000 after buying an additional 11,721 shares during the period. Hedge funds and other institutional investors own 8.13% of the company's stock.
Ambev Stock Performance
Shares of ABEV stock opened at $3.09 on Thursday. The stock's 50-day moving average is $2.96 and its two-hundred day moving average is $2.61. The firm has a market cap of $48.61 billion, a price-to-earnings ratio of 17.14, a PEG ratio of 2.16 and a beta of 0.66. Ambev S.A. has a 1 year low of $2.10 and a 1 year high of $3.24. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 0.96.
Ambev (NYSE:ABEV - Get Free Report) last issued its quarterly earnings data on Friday, February 13th. The company reported $0.05 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.05. The company had revenue of $4.50 billion for the quarter, compared to analyst estimates of $4.28 billion. Ambev had a return on equity of 16.41% and a net margin of 17.75%. Analysts predict that Ambev S.A. will post 0.18 earnings per share for the current year.
Analyst Ratings Changes
ABEV has been the topic of a number of recent research reports. Wall Street Zen lowered shares of Ambev from a "buy" rating to a "hold" rating in a research note on Monday, March 30th. Barclays upped their target price on shares of Ambev from $2.50 to $3.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 17th. Finally, Weiss Ratings raised Ambev from a "hold (c+)" rating to a "buy (b-)" rating in a report on Thursday, March 5th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $2.69.
Check Out Our Latest Stock Analysis on ABEV
Ambev Company Profile
(
Free Report)
Ambev NYSE: ABEV is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company's core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.
The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.
See Also
Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.